Molecular characterization of HLA class II binding to the LAG‐3 T cell co‐inhibitory receptor
Author:
Affiliation:
1. Division of Infection & Immunity Cardiff University Cardiff UK
2. Immutep S.A.S. Orsay France
Funder
Wellcome Trust
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202048753
Reference45 articles.
1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi F. S.;N. Engl. J. Med.,2010
2. Safety, activity, and immune correlates of anti‐PD‐1 antibody in cancer;Topalian S. L.;N. Engl. J. Med.,2012
3. Nivolumab plus ipilimumab in advanced melanoma;Wolchok J. D.;N. Engl. J. Med.,2013
4. Immune inhibitory molecules LAG‐3 and PD‐1 synergistically regulate T‐cell function to promote tumoral immune escape;Woo S.‐R.;Cancer Res.,2012
5. LAG‐3: A regulator of T‐cell and DC responses and its use in therapeutic vaccination;Triebel F.;Trends Immunol.,2003
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Structural basis for mouse LAG3 interactions with the MHC class II molecule I-Ab;Nature Communications;2024-08-29
2. Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions;Immuno;2024-07-05
3. The immune checkpoint receptor LAG3: Structure, function, and target for cancer immunotherapy;Journal of Biological Chemistry;2024-05
4. Upregulation of HLA‐II related to LAG‐3+CD4+ T cell infiltration is associated with patient outcome in human glioblastoma;Cancer Science;2024-03-13
5. A combined analysis of multi-omics data reveals the prognostic values and immunotherapy response of LAG3 in human cancers;European Journal of Medical Research;2023-12-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3